Literature DB >> 26884862

MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation.

Fengjie Guo1, Lili Guo1, Yongwen Li1, Qinghua Zhou2, Zhigang Li2.   

Abstract

MALAT1 is an important long noncoding RNA in tumor progression. Here we showed that the expression of MALAT1 was upregulated in non-small cell lung cancer cells (NSCLCs) or tissues as compared with the normal lung cell or tissues. Thus, the knockdown of MALAT1 led to decreased cell migration and invasion. Next we also found that CXCL5 as a downstream gene of MALAT1 regulated cell migration and invasion. However the regulation of MALAT1 expression was rarely known. Here we found that the treatment with SAM suppressed of MALAT1 expression. Finally, we showed that the methylated forms of MALAT1 promoter in lung cancer cells or tissues decreased compared with normal lung cells or tissues. These demonstrated that the expression of MALAT1 was dependent on the methylation. Overall, our findings illuminate the oncogenic function of MALAT1 which is regulated by DNA methylation that might provide potential clinical application in NSCLC.

Entities:  

Keywords:  CXCL5; MALAT1; cellular migration and invasion; methylation; non-small cell lung cancer

Mesh:

Substances:

Year:  2015        PMID: 26884862      PMCID: PMC4730075     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  36 in total

1.  Intronic RNAs mediate EZH2 regulation of epigenetic targets.

Authors:  Sònia Guil; Marta Soler; Anna Portela; Jordi Carrère; Elena Fonalleras; Antonio Gómez; Alberto Villanueva; Manel Esteller
Journal:  Nat Struct Mol Biol       Date:  2012-06-03       Impact factor: 15.369

2.  3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA.

Authors:  Jeremy E Wilusz; Susan M Freier; David L Spector
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

3.  CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes.

Authors:  Oksana Kowalczuk; Tomasz Burzykowski; Wieslawa Ewa Niklinska; Miroslaw Kozlowski; Lech Chyczewski; Jacek Niklinski
Journal:  Tumour Biol       Date:  2014-02-06

4.  Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion.

Authors:  Fengjie Guo; Yalin Li; Yan Liu; Jiajia Wang; Yuehui Li; Guancheng Li
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2010-03-15       Impact factor: 3.848

5.  CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.

Authors:  Mikio Kawamura; Yuji Toiyama; Kouji Tanaka; Susumu Saigusa; Yoshinaga Okugawa; Junichiro Hiro; Keiichi Uchida; Yasuhiko Mohri; Yasuhiro Inoue; Masato Kusunoki
Journal:  Eur J Cancer       Date:  2011-12-24       Impact factor: 9.162

6.  The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.

Authors:  Tony Gutschner; Monika Hämmerle; Moritz Eissmann; Jeff Hsu; Youngsoo Kim; Gene Hung; Alexey Revenko; Gayatri Arun; Marion Stentrup; Matthias Gross; Martin Zörnig; A Robert MacLeod; David L Spector; Sven Diederichs
Journal:  Cancer Res       Date:  2012-12-14       Impact factor: 12.701

7.  CXCL5 promotes prostate cancer progression.

Authors:  Lesa A Begley; Sathish Kasina; Rohit Mehra; Shreelekha Adsule; Andrew J Admon; Robert J Lonigro; Arul M Chinnaiyan; Jill A Macoska
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

Review 8.  Evolutionary conservation of long non-coding RNAs; sequence, structure, function.

Authors:  Per Johnsson; Leonard Lipovich; Dan Grandér; Kevin V Morris
Journal:  Biochim Biophys Acta       Date:  2013-10-27

9.  ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs.

Authors:  Liuqing Yang; Chunru Lin; Wen Liu; Jie Zhang; Kenneth A Ohgi; Jonathan D Grinstein; Pieter C Dorrestein; Michael G Rosenfeld
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

Review 10.  The hallmarks of cancer: a long non-coding RNA point of view.

Authors:  Tony Gutschner; Sven Diederichs
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

View more
  36 in total

1.  The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer.

Authors:  Ya-Long Zhang; Xue-Bing Li; Yan-Xu Hou; Nian-Zhen Fang; Jia-Cong You; Qing-Hua Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-01-09       Impact factor: 6.150

Review 2.  LncRNAs and miRNAs: potential biomarkers and therapeutic targets for prostate cancer.

Authors:  Guoxing Ma; Mingqing Tang; Yaqing Wu; Xiaoming Xu; Feng Pan; Ruian Xu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 3.  The crucial roles of long noncoding RNA SNHGs in lung cancer.

Authors:  Feng Chen; Fa Zhang; Yu-Fang Leng; Ya-Jing Shi; Jian-Ming Zhang; Yong-Qiang Liu
Journal:  Clin Transl Oncol       Date:  2022-08-25       Impact factor: 3.340

4.  Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells.

Authors:  Fatjon Leti; Christophe Legendre; Christopher D Still; Xin Chu; Anthony Petrick; Glenn S Gerhard; Johanna K DiStefano
Journal:  Transl Res       Date:  2017-09-19       Impact factor: 7.012

Review 5.  Role of long non-coding RNA in tumor drug resistance.

Authors:  Heng Deng; Jun Zhang; JinJun Shi; ZhengDong Guo; ChunRong He; Li Ding; Jin Hai Tang; Yong Hou
Journal:  Tumour Biol       Date:  2016-07-05

6.  Association of MALAT1 expression in gastric carcinoma and the significance of its clinicopathologic features in an Iranian patient.

Authors:  Vahid Chaleshi; Hamid Asadzadeh Aghdaei; Mahyar Nourian; Shahrokh Iravani; Hasan Jalaeikhoo; Mohsen Rajaeinejad; Ali Reza Khoshdel; Hamed Naghoosi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

7.  Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.

Authors:  Yu Zhang; Rong-Quan He; Gang Chen; Ting-Qing Gan; Yi-Wu Dang; Xiu-Ling Zhang; Xiao Wang; Su-Ning Huang; Wen-Ting Huang; Meng-Tong Jiang; Xiao-Ning Gan; You Xie; Ping Li; Dian-Zhong Luo
Journal:  Cancer Cell Int       Date:  2016-12-01       Impact factor: 5.722

Review 8.  Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.

Authors:  Fang-teng Liu; Hua Pan; Guang-feng Xia; Cheng Qiu; Zheng-ming Zhu
Journal:  Oncotarget       Date:  2016-12-13

Review 9.  Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms.

Authors:  Xiaobo Luo; Yan Qiu; Yuchen Jiang; Fangman Chen; Lu Jiang; Yu Zhou; Hongxia Dan; Xin Zeng; Yu L Lei; Qianming Chen
Journal:  Mol Cancer       Date:  2018-01-24       Impact factor: 27.401

Review 10.  Long non-coding RNAs associated with non-small cell lung cancer.

Authors:  Yuting Zhan; Hongjing Zang; Juan Feng; Junmi Lu; Lingjiao Chen; Songqing Fan
Journal:  Oncotarget       Date:  2017-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.